Serotonergic Terminals Are Differentially Affected in Parkinson's Disease: An In Vivo 11C-DASB PET Study

被引：0
|
作者：
Politis, Marios
Wu, Kit
Loane, Clare
Kiferle, Lorenzo
Molloy, Sophie
Brooks, David J.
Piccini, Paola
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A590 / A590
页数：1
相关论文
共 50 条
  • [41] Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV
    Hammoud, Dima A.
    Endres, Christopher J.
    Hammond, Edward
    Uzuner, Ovsev
    Brown, Amanda
    Nath, Avindra
    Kaplin, Adam I.
    Pomper, Martin G.
    NEUROIMAGE, 2010, 49 (03) : 2588 - 2595
  • [42] Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo 11C-BU99008 PET study
    Wilson, Heather
    Dervenoulas, George
    Pagano, Gennaro
    Tyacke, Robin J.
    Polychronis, Sotirios
    Myers, Jim
    Gunn, Roger N.
    Rabiner, Eugenii A.
    Nutt, David
    Politis, Marios
    BRAIN, 2019, 142 : 3116 - 3128
  • [43] Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates
    Tipre, DN
    Lu, JQ
    Fujita, M
    Ichise, M
    Vines, D
    Innis, RB
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (01) : 81 - 86
  • [44] Serotonin transporter is not altered in recovered depressed patients:: A [11C]dasb pet study
    Bhagwagar, Z.
    Murthy, V.
    Selvaraj, S.
    Hinz, R.
    Taylor, M.
    Fancy, S.
    Cowen, P. J.
    Grasby, P. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S110 - S110
  • [45] Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
    Norgaard, Martin
    Ganz, Melanie
    Svarer, Claus
    Frokjaer, Vibe G.
    Greve, Douglas N.
    Strother, Stephen C.
    Knudsen, Gitte M.
    NEUROIMAGE, 2019, 199 : 466 - 479
  • [46] In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
    Gerhard, A
    Pavese, N
    Hotton, G
    Turkheimer, F
    Es, M
    Hammers, A
    Eggert, K
    Oertel, W
    Banati, RB
    Brooks, DJ
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 404 - 412
  • [47] In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
    Kuhl, DE
    Minoshima, S
    Fessler, JA
    Frey, KA
    Foster, NL
    Ficaro, EP
    Wieland, DM
    Koeppe, RA
    ANNALS OF NEUROLOGY, 1996, 40 (03) : 399 - 410
  • [48] Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study
    Sommerauer, Michael
    Fedorova, Tatyana D.
    Hansen, Allan K.
    Knudsen, Karoline
    Otto, Marit
    Jeppesen, Jesper
    Frederiksen, Yoon
    Blicher, Jakob U.
    Geday, Jacob
    Nahimi, Adjmal
    Damholdt, Malene F.
    Brooks, David J.
    Borghammer, Per
    BRAIN, 2018, 141 : 496 - 504
  • [49] Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study
    Laurencin, Chloe
    Lancelot, Sophie
    Brosse, Sarah
    Merida, Ines
    Redoute, Jerome
    Greusard, Elise
    Lamberet, Ludovic
    Liotier, Veronique
    Le Bars, Didier
    Costes, Nicolas
    Thobois, Stephane
    Boulinguez, Philippe
    Ballanger, Benedicte
    BRAIN, 2024, 147 (04) : 1377 - 1388
  • [50] In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study
    Santillo, Alexander Frizell
    Gambini, Juan Pablo
    Lannfelt, Lars
    Langstrom, Bengt
    Ulla-Marja, Luohija
    Kilander, Lena
    Engler, Henry
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) : 2202 - 2208
12345